The financing round was co-led by Tencent and Flerie Invest to support Phase 1b clinical studies and pipeline expansion.
"This major fundraise is a substantial validation of both our team and our world-leading technology. We are fortunate to have the support from new and current investors who have recognised the importance of the microbiome's therapeutic potential and Microbiotica's unique capabilities."
The London-based transparency technology provider has raised new capital to develop its software and scale its team.
"Provenance is fighting greenwash with transparency tech, and helping brands unlock commercial value from their positive social and environmental impact. We’re already driving results for small independent brands and global brand groups alike, and we can’t wait to expand our community. This funding will help us grow our first-class team and product and accelerate our goal to empower 1 billion citizens to choose products that match their values."
The Bristol-based chip company raised £2.6m from Foresight Williams Technology, Verve Ventures, and u-blox to expand its laboratory and team.
"With proven capability to detect motion smaller than the size of a single electron, cavity optomechanical sensing has already had extraordinary benefits for fundamental physics research. Now, we are harnessing this power to improve the inertial sensing devices we’ve come to rely on, bringing untold new potential to drones, VR/AR, indoor navigation and imaging stabilization."